Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT)

BMC Family Practice

Volumn 16, Issue 1, 2015, Pages

  Hazen, Ankie C M ^a   Sloeserwij, Vivianne M ^a   Zwart, Dorien L M ^a   De Bont, Antoinette A ^b   Bouvy, Marcel L ^c   De Gier, Johan J ^d   De Wit, Niek J ^a   Leendertse, Anne J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

General practice; Hospitalisation; Non dispensing clinical pharmacist; Pharmacotherapy; Polypharmacy; Primary care

Indexed keywords

CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENERAL PRACTICE; HOSPITALIZATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MEDICATION ERROR; NETHERLANDS; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PHARMACIST; PHARMACY; POLYPHARMACY; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; PROFESSIONAL STANDARD; STATISTICS AND NUMERICAL DATA;

CLINICAL PROTOCOLS; COMMUNITY PHARMACY SERVICES; DELIVERY OF HEALTH CARE, INTEGRATED; GENERAL PRACTICE; HOSPITALIZATION; HUMANS; MEDICATION ERRORS; NETHERLANDS; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; PHARMACISTS; POLYPHARMACY; PRIMARY HEALTH CARE; PROFESSIONAL ROLE;

EID: 84933506819     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-015-0296-8     Document Type: Article

References (31)

1. Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890-6.
2. Denneboom W, Dautzenberg MG, Grol R, de Smet PA. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract. 2007;57:723-31.
3. Kwint HF, Faber A, Gussekloo J, Bouvy ML. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study. Drugs Aging. 2011;28:305-14.
4. Stuijt CC, Franssen EJ, Egberts AC, Hudson SA. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25:947-54.
5. Vinks TH, Egberts TC, de Lange TM, de Koning FH. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26:123-33.
6. Kempen TG, van de Steeg-van Gompel CH, Hoogland P, Liu Y, Bouvy ML. Large scale implementation of clinical medication reviews in Dutch community pharmacies: drug-related problems and interventions. Int J Clin Pharm. 2014;36:630-5.
7. Chau SH, Jansen APD, van de Ven PM, Hoogland P, Elders PJM, Hugtenburg JG. Medicatiebeoordelingen in de openbare apotheek: prevalentie van geneesmiddelgerelateerde problemen bij ouderen met polyfarmacie en inzicht in patiënt-, behaldelings- en ziektegerelateerde factoren. PW Wetenschappelijk Platform. 2014;8:a1428.
8. Leendertse AJ. Dissertation: Hospital admissions related to medication: prevalence, provocation and prevention. Chapter 3.2 The effect of a pharmaceutical care process intervention on medication-related hospital admissions in the elderly in an integrated primary care setting: results of the PHARM study, Appendix "The discrepancy between intended and actual number of included patients in the PHARM-study". p. 159-62.
9. Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practioners in the United Kingdom. Soc Sci Med. 2001;53:943-55.
10. Farris KB, Côté I, Feeny D, Johnson JA, Tsuyuki RT, Brilliant S, Dieleman S. Enhancing primary care for complex patients. Demonstration project using multidisciplinary teams. Can Fam Physician. 2004;50:998-1003.
11. Kwint HF, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30:91-102.
12. McDonough RP, Doucette WR. Dynamics of pharmaceutical care: developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2001;41:682-92.
13. D'Amour D, Ferrada-Videla M, San Martin Rodriguez L, Beaulieu MD. The conceptual basis for interprofessional collaboration: core concepts and theoretical frameworks. J Interprof Care. 2005;19 Suppl 1:116-31.
14. Dolovich L, Pottie K, Kaczorowski J, Farrell B, Austin Z, Rodriguez C, Gaebel K, Sellors C. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther. 2008;83:913-7.
15. Hogg W, Lemelin J, Dahrouge S, Liddy C, Armstrong CD, Legault F, Dalziel B, Zhang W. Randomized controlled trial of anticipatory and preventive multidisciplinary team care. Can Fam Physician. 2009;55:e76-85.
16. Tan ECK, Stewart K, Elliott RA, George J. Pharmacist consultations in general practice clinics: The Pharmacists in Practice Study (PIPS). Res Social Adm Pharm. 2013:1-11.
17. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother. 2001;35:835-40.
18. NHG: Nederlands Huisartsen Genootschap. https://www.nhg.org/ Accessed 19 June 2015.
19. Periodieke Individuele Analyse Farmacotherapie (PIAF). http://www.paofarmacie.nl/uploads/files/folder-PIAF-def.pdf Accessed 19 June 2015.
20. Service Apotheek Farmacotherapie Expert opleiding. http://www.serviceapotheeknascholing.net/ Accessed 19 June 2015.
21. CanMEDS: better standards, better physicians, better care. http://www.royalcollege.ca/portal/page/portal/rc/resources/aboutcanmeds. Accessed 19 June 2014.
22. Balint M. The doctor, his patient and the illness. 1st ed. London: Pitman Medical Publishing; 1964.
23. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA. 1979;242:623-32.
24. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.
25. Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham G, Harris TB, Hanlon JT, Rubin SM, Shorr RI, Bauer DC, Abernethy DR. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781-7.
26. Leendertse AJ, de Koning FHP, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Ebgerts TCG, van den Bemt PMLA. Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther. 2013;38:379-87.
27. Vermunt JD, Verloop N. Congruence and friction between learning and teachingCongruence and friction between learning and teaching. Learn Instr. 1999;9:257-280.
28. Kolb DA. The process of experiential learning. In: Kolb DA, editor. Experiential learning: experience as the source of learning and development. Englewood Cliffs, New Jersey: Prentice Hall Inc.; 1984. p. 20-38.
29. van Merriënboer JJG. Training complex cognitive skills: a four component instructional design model for technical training. Englewood Cliffs, New Jersey: Educational Technology; 1997.
30. Nederlandse artseneed. http://knmg.artsennet.nl/Publicaties/KNMGpublicatie/62487/Nederlandse-artseneed-inclusief-Eed-van-Hippocrates-Verklaring-van-Geneve-2004.htm Accessed 19 June 2015.
31. van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJ, Verhamme KM, Stricker BH, Sturkenboom MC. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf. 2008;17:365-71.